Current concepts in combination antibiotic therapy for critically ill patients

被引:70
作者
Ahmed, Armin [1 ]
Azim, Afzal [1 ]
Gurjar, Mohan [1 ]
Baronia, Arvind Kumar [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Crit Care Med, Lucknow 226014, Uttar Pradesh, India
关键词
Carbapenem-resistant enterobacteriaceae; combination antibiotic therapy; Klebsiella pneumoniae carbapenemase; sepsis;
D O I
10.4103/0972-5229.132495
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Widespread emergence of multidrug resistant (MDR) bacterial pathogens is a problem of global dimension. MDR infections are difficult to treat and frequently associated with high mortality. More than one antibiotic is commonly used to treat such infections, but scientific evidence does not favor use of combination therapy in most cases. However, there are certain subgroups where combination therapy may be beneficial, e.g. sepsis due to carbapenem-resistant Enterobacteriaceae (CRE), bacteremic pneumococcal pneumonia, and patients with multiple organ failure. Well-designed prospective studies are needed to clearly define the role of combination therapy in these subgroups.
引用
收藏
页码:310 / 314
页数:5
相关论文
共 25 条
[1]   Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria [J].
Arnold, Ryan S. ;
Thom, Kerri A. ;
Sharma, Saarika ;
Phillips, Michael ;
Johnson, J. Kristie ;
Morgan, Daniel J. .
SOUTHERN MEDICAL JOURNAL, 2011, 104 (01) :40-45
[2]  
Chen Luke F, 2012, Infect Drug Resist, V5, P133, DOI 10.2147/IDR.S26613
[3]   Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? [J].
Daikos, G. L. ;
Markogiannakis, A. .
CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (08) :1135-1141
[4]   Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial [J].
Durante-Mangoni, Emanuele ;
Signoriello, Giuseppe ;
Andini, Roberto ;
Mattei, Annunziata ;
De Cristoforo, Maria ;
Murino, Patrizia ;
Bassetti, Matteo ;
Malacarne, Paolo ;
Petrosillo, Nicola ;
Galdieri, Nicola ;
Mocavero, Paola ;
Corcione, Antonio ;
Viscoli, Claudio ;
Zarrilli, Raffaele ;
Gallo, Ciro ;
Utili, Riccardo .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (03) :349-358
[5]   Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention [J].
Gupta, Neil ;
Limbago, Brandi M. ;
Patel, Jean B. ;
Kallen, Alexander J. .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (01) :60-67
[6]   Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection [J].
Hirsch, Elizabeth B. ;
Tam, Vincent H. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) :1119-1125
[7]   Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients [J].
Kollef, MH .
CLINICAL INFECTIOUS DISEASES, 2000, 31 :S131-S138
[8]   Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock [J].
Kumar, Anand ;
Ellis, Paul ;
Arabi, Yaseen ;
Roberts, Dan ;
Light, Bruce ;
Parrillo, Joseph E. ;
Dodek, Peter ;
Wood, Gordon ;
Kumar, Aseem ;
Simon, David ;
Peters, Cheryl ;
Ahsan, Muhammad ;
Chateau, Dan .
CHEST, 2009, 136 (05) :1237-1248
[9]   Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study [J].
Kumarasamy, Karthikeyan K. ;
Toleman, Mark A. ;
Walsh, Timothy R. ;
Bagaria, Jay ;
Butt, Fafhana ;
Balakrishnan, Ravikumar ;
Chaudhary, Uma ;
Doumith, Michel ;
Giske, Christian G. ;
Irfan, Seema ;
Krishnan, Padma ;
Kumar, Anil V. ;
Maharjan, Sunil ;
Mushtaq, Shazad ;
Noorie, Tabassum ;
Paterson, David L. ;
Pearson, Andrew ;
Perry, Claire ;
Pike, Rachel ;
Rao, Bhargavi ;
Ray, Ujjwayini ;
Sarma, Jayanta B. ;
Sharma, Madhu ;
Sheridan, Elizabeth ;
Thirunarayan, Mandayam A. ;
Turton, Jane ;
Upadhyay, Supriya ;
Warner, Marina ;
Welfare, William ;
Livermore, David M. ;
Woodford, Neil .
LANCET INFECTIOUS DISEASES, 2010, 10 (09) :597-602
[10]   Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for infection and impact of resistance on outcomes [J].
Lautenbach, E ;
Patel, JB ;
Bilker, WB ;
Edelstein, PH ;
Fishman, NO .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (08) :1162-1171